Page last updated: 2024-09-04

rp 73401 and pentoxifylline

rp 73401 has been researched along with pentoxifylline in 2 studies

Compound Research Comparison

Studies (rp 73401)	Trials (rp 73401)	Recent Studies (post-2010) (rp 73401)	Studies (pentoxifylline)	Trials (pentoxifylline)	Recent Studies (post-2010) (pentoxifylline)
92	0	23	4,437	657	943

Protein Interaction Comparison

Protein	Taxonomy	rp 73401 (IC50)	pentoxifylline (IC50)
Acetylcholinesterase	Homo sapiens (human)		6.6

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Esch, IJ; de Graaf, C; Jansen, C; Kanev, GK; Kooistra, AJ; Leurs, R	1
Bourguignon, JJ; Lugnier, C; Muller, CD; Pinna, G; Raboisson, P; Reimund, JM	1

Other Studies

2 other study(ies) available for rp 73401 and pentoxifylline

Article	Year
PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design. Journal of medicinal chemistry, 2016, Aug-11, Volume: 59, Issue:15 Topics: Databases, Protein; Dose-Response Relationship, Drug; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship	2016
Anti-TNF-alpha properties of new 9-benzyladenine derivatives with selective phosphodiesterase-4- inhibiting properties. Biochemical and biophysical research communications, 2001, Oct-26, Volume: 288, Issue:2 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Benzamides; Cell Survival; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Drug Interactions; Humans; Interleukin-1; Interleukin-6; Interleukin-8; Leukocytes, Mononuclear; Lipopolysaccharides; Pentoxifylline; Phosphodiesterase Inhibitors; Pyridines; Tumor Necrosis Factor-alpha; Xanthines	2001

Article

Year

PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design.

Journal of medicinal chemistry, 2016, Aug-11, Volume: 59, Issue:15

Topics: Databases, Protein; Dose-Response Relationship, Drug; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship

2016

Anti-TNF-alpha properties of new 9-benzyladenine derivatives with selective phosphodiesterase-4- inhibiting properties.

Biochemical and biophysical research communications, 2001, Oct-26, Volume: 288, Issue:2

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Benzamides; Cell Survival; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Drug Interactions; Humans; Interleukin-1; Interleukin-6; Interleukin-8; Leukocytes, Mononuclear; Lipopolysaccharides; Pentoxifylline; Phosphodiesterase Inhibitors; Pyridines; Tumor Necrosis Factor-alpha; Xanthines

2001